系统代谢交叉作为癌症缓解症的驱动因素
Elisabeth Wyart1, Giovanna Carrà2, Elia Angelino3
1Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, 10126 Torino, Italy.
Trends in endocrinology and metabolism: TEM
|January 5, 2025
概括
卡切西亚涉及复杂的代谢变化,导致组织损耗. 本综述探讨了缓解症的系统代谢变化,超越了特定器官的观点,了解其在疾病进展中的积极作用.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 病理生理学 病理生理学
- 系统生物学 系统生物学
背景情况:
- 卡赫西亚是一种复杂的代谢障碍,具有负能量平衡,导致组织浪费.
- 人们越来越认识到新陈代谢是疾病进展的关键调节者,而不仅仅是被动因素.
- 现在,人们理解白内障是一种活跃的过程,而不仅仅是癌症等疾病的后果.
研究的目的:
- 为了给出一种概述,介绍缓解症中的代谢变化.
- 突出这些代谢变化的潜在系统影响.
- 将特定器官的代谢失调纳入一个全面的框架.
主要方法:
- 文献综述 文献综述 文献综述
- 综合目前关于缓解症代谢的研究.
- 对系统代谢变化的分析.
主要成果:
- 缓冲症中的代谢失调经常被孤立地研究,限制了整体的理解.
- 需要一个框架,将特定器官的代谢变化与系统性影响联系起来.
- 代谢变化在缓解症的进展中起着至关重要的作用.
结论:
- 对代谢变化的系统性观察对于理解缓存症至关重要.
- 进一步的研究应侧重于整合代谢洞察力,以建立全面的疾病模型.
- 了解系统代谢影响可以为缓冲症的治疗策略提供信息.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K


